The Amprion Story | Early Prion Detection for Alzheimer's & Parkinson's
News

The Amprion Story

By March 27, 2018 No Comments

Discover why early diagnosis for Alzheimer’s and Parkinson’s has been so challenging until now. And why fighting Alzheimer’s disease is critically important on a global scale. Meet Amprion, a biotech company with groundbreaking Early Detection science to track the biomarkers (aka prion-particles or misfolded proteins) that cause these neurodegenerative diseases. Amprion’s revolutionary early detection technology tracks all three misfolded proteins: Abeta amyloid, Tau and Synuclein prior to any clinical symptoms. Our mission is to empower people to navigate their brain health. We’re fighting against Alzheimer’s and Parkinson’s. Join the Fight! #JTFBrainHealth